SCHEMBL29941595

SCHEMBL29941595

Cc1ncnc2c1CSCC2

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.41
▸ PARP15 Q460N3 1/20 0.41
▸ PARP3 Q9Y6F1 1/20 0.41
▸ TNKS2 Q9H2K2 2/20 0.32
▸ TNKS O95271 1/20 0.32
▸ DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23599064 0.82 — —
SCHEMBL16079383 0.71 KDM4E (0.45) DRD1
SCHEMBL1586120 0.71 DRD1 (0.48) DRD1
SCHEMBL24954134 0.71 PARP1 (0.50) PARP1PARP15PARP3TNKS2TNKS
SCHEMBL15127493 0.69 KDM4E (0.44) DRD1
SCHEMBL10267839 0.68 KDM4E (0.33) DRD1
SCHEMBL23752392 0.68 KDM4E (0.56) PARP1PARP15PARP3TNKS2TNKS
SCHEMBL23921714 0.67 — —
SCHEMBL12333209 0.67 HTR2A (0.35) DRD1
SCHEMBL404362 0.64 CYP2C19 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 — — US disclosed
Send feedback